A Study to Evaluate BOTOX® in Participants with Overactive Bladder and Urinary Incontinence

Overview

About this study

The purpose of this study is to evaluate the effectiveness and safety of BOTOX® intravesical instillation in participants with overactive bladder and urinary incontinence.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • Symptoms of OAB (frequency/urgency) with urinary incontinence for at least 6 months.
  • Inadequate response or limiting side effects with pharmacotherapy for the treatment of OAB.

Exclusion Criteria: 

  • Overactive Bladder caused by neurological condition.
  • Patient has predominance of stress incontinence.
  • History or evidence of pelvic or urological abnormality.
  • Prior use of BOTOX for any urological condition

More information

Publications

Publications are currently not available
.
CLS-20467882

Mayo Clinic Footer